Illness kept changing the rules of Scott Spolverino’s life. His obsession with flavor led from tea to whisky and, eventually, cannabis.
Chemical Engineer (and distiller) turned California sober, living in the Hudson Valley of New York. He enjoys a good spliff, ...
Temple balls, pressed dry sift, little cosmetic jars of sand. David Downs reports from the third annual SF Hash Week on the ...
New Jersey’s Good Times uses cannabinoid ratios, fast-acting gummies, and sharp flavor design to make legal weed easier to ...
Before he founded High Times, Tom Forçade threw a cheese pie at a member of the Commission on Obscenity and Pornography. The ...
Thailand is moving closer to putting its medical-only cannabis model into national law, with a new bill that would require licenses across the supply chain, ...
New Jersey pulls THC drinks from liquor stores on November 13. High Tide explains what the deadline changes and where ...
The Netherlands’ regulated cannabis experiment is already reshaping coffeeshop shelves, expanding product variety and driving down flower prices. But early findings show little change in consumption, ...
Ecuador’s hemp sector is projected to approach or surpass $20 million in 2026 as companies move beyond raw biomass into ...
The grower, author and longtime High Times columnist sat down for episode 200 of the Good PizzZa podcast and walked through ...
This Company Wants to Sell the ‘World’s First’ CBD Pain Tablet. Its Own Trial Didn’t Beat a Placebo.
An Australian company has filed for approval of a THC-free CBD tablet it calls a world first for chronic pain. Its chief executive told 7News the trial didn't outperform placebo.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results